Where does Isis Pharmaceuticals, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Isis Pharmaceuticals, Inc. ranks #6,448 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Isis Pharmaceuticals, Inc. hold?

Isis Pharmaceuticals, Inc. holds 52 US utility patents granted between 2015 and 2020, spanning 10 technology areas.

What is Isis Pharmaceuticals, Inc.'s Innovation Score?

Isis Pharmaceuticals, Inc. has an Innovation Score of 37.8 out of 100 (top 43% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Isis Pharmaceuticals, Inc.'s patent grant rate increasing or decreasing?

Isis Pharmaceuticals, Inc.'s recent grant velocity is -98% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Isis Pharmaceuticals, Inc.'s patents?

Isis Pharmaceuticals, Inc.'s patents average 21.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Isis Pharmaceuticals, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Isis Pharmaceuticals, Inc.

Q: What technology areas does Isis Pharmaceuticals, Inc. focus on?

Isis Pharmaceuticals, Inc.'s top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 45 patents, ranking #232 of 4,144 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

USPTO PatentsView assignee record - 52 granted patents across 10 technology areas, recorded in grant years 2015–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Isis ranks #6,448 of 49,997 tracked US assignees by granted-patent volume, with 52 patents across 10 technology areas.

#6,448
of 49,997 US assignees by volume: Top 43%
by Innovation Score (37.8/100): 21.5
avg claims per patent: -98%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6448 · US Corporation #6,448 · 52 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 52 grants
UPPER-Q #6,448/49,997
PHOTO-FINISH InContact
CPC-FOCUS C12N · 10 areas
INNOV-THIN 37.8/100
CLAIMS-DENSE 21.5 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -98% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: InContact Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Isis’s 37.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.7 pts (36%) Velocity 0.0 pts (0%) Breadth 11.2 pts (30%) Claim depth 12.9 pts (34%)

Qualcomm Incorporated · highest

85
Isis Pharmaceuticals · this assignee

38
Powdertech · near

38
The Safety Network… · near

38
THE United States… · near

38
Transmural Systems · near

38
3D Lighting… · lowest

7

What this shows Isis's Innovation Score is 37.8/100 (top 43% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Isis?

Each dot is one of Isis’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Isis’s own 21.5 claims/patent is ABOVE the 11.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Isis vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Isis's grants concentrate

Isis Pharmaceuticals, Inc. is a focused PatentsView assignee: 10 CPC subclasses with 86.5% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2015 (47 grants) versus a trough of 1 in 2019. By volume, Isis sits between Inertech IP LLC and Kyushu University.

Inertech IP

52
Inje University I…

52
Institut Gustave…

52
Incontact

52
JBF Interlude 2009

52
Jenoptik Optical…

52
Kyowa Hakko BIO

52
Kyushu University

52
Isis Pharmaceutic… ◀

52

What this shows Isis holds 52 patents at rank #6,448, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Isis

By rank, the assignees closest to #6,448 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Isis's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Isis, neither rank-band nor same-CPC leaders (those blocks stay above). In C12N (Microorganisms OR Enzymes), Isis ranks #232 of 4,144 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (38 here).

Powdertech Co., Ltd. 38 Transmural Systems LLC 38 THE United States OF America, AS Represented BY THE Secretary, Department OF Health AND Human Services, Office OF Technology TRANSFER—NATIONAL Institutes OF Health 38 The Safety Network Partnership, LLC 38

Similar claim depth

Nearest assignees by average claims per patent (21.5 here).

Arthrosurface Incorporated 21.5 avg CPG Technologies, LLC 21.5 avg Proton World International N.V. 21.5 avg Uhnder, Inc. 21.5 avg

Isis's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 43% higher than 57% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Isis Pharmaceuticals, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	47	90.4%
2016	3	5.8%
2019	1	1.9%
2020	1	1.9%

Which technologies does Isis Pharmaceuticals, Inc. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 45

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 34

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 25

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 18

C12Y - Enzymes 10

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 4

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 2

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 1

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Isis Pharmaceuticals, Inc.'s patent record in context - here's where to go next.

Isis Pharmaceuticals, Inc.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 86.5% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #6,448 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Isis Pharmaceuticals, Inc. against Inertech IP LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 37.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.